Key Lipid Reprogramming Revealed in Gastric Signet Ring Cell Carcinoma by Spatial Mass Spectrometry Metabolomics
Journal of the American Society for Mass Spectrometry · 2025
DOI: 10.1021/jasms.4c00505 ↗At a glance
Journal article in Journal of the American Society for Mass Spectrometry, 2025. Written by Yuying Shi and 13 co-authors. Institution: National Science Library (Chengdu), Chinese Academy of Sciences, Chengdu 610299, China. Major MEDLINE topics: Stomach Neoplasms, Carcinoma, Signet Ring Cell, Metabolomics, Lipid Metabolism. Cited 6 times so far (Crossref); 72 references. Funded by: National Key Research and Development Program of China, China Postdoctoral Science Foundation, Shandong University.
Abstract (original language)
Gastric signet ring cell carcinoma (GSRC) is an aggressive subtype of gastric cancer (GC) with a poor prognosis. The lack of a systematic molecular and metabolic heterogeneity overview has led to slow progress in clinical practice. This study used mass spectrometry imaging (MSI) to investigate the metabolic landscape of GSRC in GC tissue with various differentiation grades. Our comprehensive spatial profiling of metabolites and lipids unveiled distinct metabolic signatures across different tissue subregions. A substantial number of lipidomic biomarkers associated with GSRC were identified, including phosphatidylethanolamine N -methyl (PE-NMe), phosphatidylethanolamine (PE), sphingomyelin (SM), diacylglycerol (DG), phosphatidic acid (PA), and phosphatidylcholine (PC), which may provide insights into its pathogenesis and potential therapeutic targets. Furthermore, multi-omics network analysis revealed intricate metabolic pathways involved in GSRC progression. Our findings highlight the importance of understanding the metabolic heterogeneity of GSRC and pave the way for future studies exploring its clinical implications and therapeutic strategies.
Subjects
MeSH terms (MEDLINE)
Author keywords
Substances
Authors and institutions
- National Science Library (Chengdu), Chinese Academy of Sciences, Chengdu 610299, China.
- Department of Biostatistics, School of Public Health, Cheeloo College of Medicine, Shandong University, Jinan 250012, China.
- National Institute of Health Data Science of China, Shandong University, Jinan 250012, China.
- National Synchrotron Radiation Laboratory, University of Science and Technology of China, Hefei 230029, China.
- Department of Gastrointestinal Surgery, Shandong Cancer Hospital and Institute, Shandong First Medical University and Shandong Academy of Medical Science, Jinan 250012, China.
- School of Life Sciences, and Biomedical Pioneering Innovation Center (BIOPIC), Peking University, Beijing 100871, China.
ORCID profiles: Yang Pan, Tao Zhang, Cheng Wang
Funding
- National Key Research and Development Program of China
- China Postdoctoral Science Foundation
- Shandong University
- National Natural Science Foundation of China
- Natural Science Foundation of Shandong Province
Cite
APA
Shi, Y., Yang, Q., Xu, B., Yuan, C., Qi, K., Pan, Y., Wang, Z., Chen, Q., Sun, D., Zhao, W., Zhang, T., Liu, C., Wang, C., & Chai, J. (2025). Key Lipid Reprogramming Revealed in Gastric Signet Ring Cell Carcinoma by Spatial Mass Spectrometry Metabolomics. Journal of the American Society for Mass Spectrometry. https://doi.org/10.1021/jasms.4c00505
Vancouver
Shi Y, Yang Q, Xu B, Yuan C, Qi K, Pan Y, et al. Key Lipid Reprogramming Revealed in Gastric Signet Ring Cell Carcinoma by Spatial Mass Spectrometry Metabolomics. Journal of the American Society for Mass Spectrometry. 2025. doi:10.1021/jasms.4c00505
BibTeX
@article{Shi2025,
author = {Shi, Yuying and Yang, Qi and Xu, Botao and Yuan, Chuang and Qi, Keke and Pan, Yang and Wang, Zhe and Chen, Qitao and Sun, Dong and Zhao, Weizhu and Zhang, Tao and Liu, Chengyuan and Wang, Cheng and Chai, Jie},
title = {Key Lipid Reprogramming Revealed in Gastric Signet Ring Cell Carcinoma by Spatial Mass Spectrometry Metabolomics},
journal = {Journal of the American Society for Mass Spectrometry},
year = {2025},
doi = {10.1021/jasms.4c00505}
}
EUVIMED